Stock Watch: J&J And Novartis Fire Opening Salvos Of Earnings Season
Reports Differ In Outlook And Reception
Executive Summary
J&J’s bullish outlook for 2021, robust fourth quarter and frequent guidance revisions in uncertain times contrasted with Novartis’s reticence.